Hunter Renfrow saw his NFL career temporarily halted after being diagnosed with ulcerative colitis. He's hoping to return to ...

DelveInsight’s “Ulcerative Colitis Market Insights, Epidemiology and Market Forecast – 2034” report delivers an in-depth ...

Recent years have seen significant advancements in UC treatment, offering renewed hope for patients seeking effective and ...

Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative ...

Research shows that smoking may have beneficial effects on symptoms of ulcerative colitis. But the risks of starting this ...

Anissa Armet, a dietitian and nutrition researcher, helped to create the NiMe diet, which was linked to better gut health in ...

Microba Life Sciences Limited (ASX: MAP) ("Microba") a precision microbiome company, today announces two significant ...

Option Care Health, Inc.’s OPCH share price has dipped by 6.43%, which has investors questioning if this is right time to buy ...

The approval was based on data from the randomized, double-blind, placebo-controlled phase 3 SELECT-GCA trial.

Digestive disorders can affect us all from time to time. Symptoms such as bloating and pain, often accompanied with some ...

AbbVie today announced the U.S. Food and Drug Administration (FDA) has approved RINVOQ® (upadacitinib), 15 mg, once daily, for the treatment of adults with giant cell arteritis (GCA).1 This comes ...